Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. Request Sample

Urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions.

The global urinalysis market is estimated to account for US$ 1,249.0 Mn in terms of value and is expected to reach US$ 1,779.9 Mn by the end of 2027.

Global Urinalysis Market: Drivers

Increasing prevalence of kidney diseases is expected to propel growth of the global urinalysis market over the forecast period. For instance, according to European Renal Association – European Dialysis and Transplant Association’s data in 2018, over 850 million people worldwide have some form of kidney disease.

Moreover, increasing geriatric population is also expected to boost demand for urinalysis. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.

Consumables held dominant position in the global urinalysis market in 2019, accounting for 67.5% share in terms of volume, followed by Instruments.

Figure 1. Global Urinalysis Market Share (%), by Value, by Product Type, 2019

Global Urinalysis Market: Restraints

High cost associated with advanced analyzers is expected to hinder growth of the global urinalysis market. For instance, ARKRAY, Inc.’s AUTION MAX AX-4060 urine analyzer costs around US$ 72,000, almost 10 times more than conventional urine analyzers.

Moreover, high capital investment required to set up a modern laboratory is also expected to limit growth of the global urinalysis market.

Urinalysis Market Report Coverage Report Coverage Details Base Year: 2019 Market Size in 2019: US$ 1,183.7 Mn Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027 Forecast Period 2020 to 2027 CAGR: 5.2% 2027 Value Projection: US$ 1,779.9 Mn Geographies covered: North America: U.S., Canada

U.S., Canada Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Brazil, Argentina, Mexico, Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe

Germany, U.K., Spain, France, Italy, Russia, Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific

China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific Middle East: GCC Countries, Israel, Rest of Middle East

GCC Countries, Israel, Rest of Middle East Africa: South Africa, North Africa, Central Africa Segments covered: By Product Type: Instruments, Consumables.

Instruments, Consumables. By Test Type: Macroscopic, Chemistry, Microscopic/Sediment.

Macroscopic, Chemistry, Microscopic/Sediment. By Test Setting: Point-of-Care, Laboratory-based.

Point-of-Care, Laboratory-based. By End User: Hospitals, Independent Laboratories, Physician Practices, Others (Industrial, Institutions, Home Testing, Nursing Facility, etc.). Companies covered: Alere, Bio-Rad Laboratories, Inc., Roche Diagnostics, Mindray, Healthy.io, Arkray, Inc., Sysmex America, Inc., Beckman Coulter, and Siemens Healthcare. Growth Drivers: Increasing prevalence of kidney diseases

Increasing geriatric population Restraints & Challenges: High cost associated with advanced analyzers

High capital investment required to set up a modern laboratory

Global Urinalysis Market: Opportunities

Development of semi-automated urinalysis is expected to offer lucrative growth opportunities for players in the global urinalysis market. For instance, in September 2019, researchers from University of Arkansas, U.S., reported that acridine orange as an aid for point-of-care urinalysis systems is a feasible solution.

Moreover, adoption of easy to use, rapid, and inexpensive diaper-based testing devices in urinalysis is also expected to aid in growth of the global urinalysis market.

The global urinalysis market was valued at US$ 1,183.7 Mn in 2019 and is forecast to reach a value of US$ 1,779.9 Mn by 2027 at a CAGR of 5.2% between 2020 and 2027.

Figure 2. Global Urinalysis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

High prevalence of diabetes is expected to propel growth of the global urinalysis market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Moreover, launch of smartphone-based urinalysis is also expected to aid in growth of the market. For instance, in July 2019, Healthy.io, a smartphone camera-based solutions developer, announced an agreement with Walgreens Boots Alliance, Inc. placing Healthy.io's Dip UTI test kits in Boots pharmacies throughout the United Kingdom.

Global Urinalysis Market: Competitive Landscape

Major players operating in the global urinalysis market include, e Alere, Bio-Rad Laboratories, Inc., Roche Diagnostics, Mindray, Healthy.io, Arkray, Inc., Sysmex America, Inc., Beckman Coulter, and Siemens Healthcare.

Global Urinalysis Market: Key Developments

Major players in the global urinalysis market are focused on offering solutions to address data privacy security and compliance concerns. For instance, in August 2020, Sysmex America, Inc. launched Caresphere Workflow Solution, its new clinical software application designed to address data privacy security and compliance concerns.

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in June 2020, Healthy.io acquired Inui Health, a home-diagnostics company, in a US$ 9 million cash deal.